Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 2Spinal Fractures 1Spinal Diseases 1Multiple Myeloma 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Vertebroplasty × Clear all
NCT00819832 2023-03-24

Anderson Circulating Tumor Cell Burden (CTCB) Study

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 2 charts

Neoplasms, Spinal Diseases

NCT02376933 2018-11-07

Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer

University of Arizona

Phase NA Terminated
11 enrolled 6 charts
Plasma cell

Multiple Myeloma, Neoplasms, Spinal Fractures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡